A jury in Philadelphia ruled that Pfizer Inc. properly warned about the risks that its Zoloft antidepressant could cause birth defects and isn’t responsible for a girl’s heart abnormalities. It is the drugmaker’s second win in cases over the medication.
The Philadelphia jury rejected Mia Robinson’s claims that Pfizer officials hid Zoloft’s birth-defect risks and should pay at least $2.4 million to compensate the eight-year-old girl for her heart abnormalities.
The company persuaded a St. Louis jury in April to reject a family’s arguments that the drug caused a boy’s cardiac abnormalities in the first of more than 1,000 lawsuits over the medication to go to trial.
The case is Robinson v. Wolters Kluwer Health Inc., July Term, 2011, No. 778, Control No. 14123047, Pennsylvania Court of Common Pleas of Philadelphia County (Philadelphia).